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Summary
Natural killer cell stimulatory factor (NKSF), or interleukin 12 (IL12), is a 70-kD heterodimeric
cytokine composed of two covalently linked chains, p40 and p35 . NKSFAL12 has multiple effects
on T andNK cells and was originally identified and purified from the supernatant fluid of Epstein-
Barr virus (EBV)-transformed human B lymphoblastoid cell lines. We have produced a panel
of monoclonal antibodies against both chains of NKSFAL12 . Some of these antibodies have
neutralizing activity, and several combinations of them have been used to establish sensitive
radioimmunoassays detecting the free p40 chain, the free p35 chain, or the p70 heterodimer.
Using these reagents, we have determined that most EBVtransformed human B lymphoblastoid
cell lines constitutively produce low levels of the p70 heterodimer and an excess of the free p40
chain, whereas Burkitt lymphoma-derived, T, myeloid, and many solid tumor-derived cell lines
produce neither. Production of both p40 and p70 is increased several-fold upon stimulation of
the EBVtransformed cell lines with phorbol diesters . The ability of supernatant fluids from
unstimulated and phorbol diester-stimulated cell lines to induce interferon y (IFN-y) production
from T and NK cells, one of the effects of NKSFAL12, parallels the levels of production of
the p70 heterodimer, known to be the biologically active form of NKSFAL12 . Staphylococcus
aureus Cowan I strain (SAC) and other stimuli induce accumulation ofp40 mRNA and production
of both p40 and p70 by peripheral blood mononuclear cells (PBMC) . The producer cells appear
to include both adherent cells and nonadherent lymphocytes, possibly B cells. The supernatant
fluids from SAC-stimulated PBMC mediate the typical functions of NKSFAL12 (i.e., IFN-y
induction, mitogenic effects on T/NK blasts, enhancement ofNK cell cytotoxicity) at concentrations
of p70 similar to those at which recombinant NKSFAL12 mediates the same functions . Moreover,
these activities are significantly inhibited by anti-NKSF/IL12 antibodies . The neutralizing anti-
NKSF/IL12 antibodies also inhibit 85% of the IFN-y production in response to SAC, an NKSF/IL
12 inducer, and approximately 50% of the IFN-y production in response to non-NKSF/IL12-
inducers such as IL-2, phytohemaglutinin, and anti-CD3 antibodies . These results indicate that
induced or constitutively producedNKSFAL12 has a major role in facilitating IFN-y production
by peripheral blood lymphocytes . Our findings that NKSFAL12 is both spontaneously produced
and inducible in adherent PBMC and lymphocytes suggest that NKSFAL12 might be a major
physiological regulator ofT and NK cell function during animmune response and inflammation .
i A. D'Andrea and M . Rengaraju contributed equally to this work .
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Volume 176 November 1992 1387-1398N atural killer cell stimulatory factor (NKSF)z is a het-
erodimeric cytokine originally identified and purified
from the conditioned medium of EBVtransformed human
B lymphoblastoid cell lines (1) . The terms cytotoxic lym-
phocyte maturation factor (CLMF) and IL12 have also been
used to describe this cytokine (2, 3) . The genes encoding
thetwo chains ofNKSF/IL12 (p40 and p35) have been cloned
in humans (3, 4) and recently in the mouse (5) . The two
chains are covalently linked to form a biologically active p70
heterodimer, whereas no biological activity has been shown
to be mediated by either recombinant chain separately (4) .
However, B cell lines, producing biologically active NKSF/
IL-12 p70, also produce a large excess of free p40 chain, the
exact significance ofwhich is notknown (1, 3) . The p35 chain
has a structure similar to other a helix-rich cytokines, whereas
the p40 chain has homology not with other cytokines but
with the extracellular portion of proteins of the hemopoietin
receptor family, particularly with the receptor for ciliary neu-
rotrophic factor and with the receptor for IL-6, suggesting
that the two chains of NKSF/IL12 might be derived from
a primordial cytokine-receptor complex (5-7) .
NKSF/IL12 has multiple effects on both T and NK cells.
Specifically, NKSF/IL12 : (a) induces production of IFN-y
and other cytokines (e.g ., TNF) by both resting and acti-
vated T and NK cells (1, 8, and Chehimi, J ., N .M . Valiante,
A. D'Andrea, M . Rengaraju, Z . Rosado, M . Kobayashi, B.
Perussia, S . F. Wolf, S. E . Starr, and G . Trinchieri, manu-
script submitted for publication) ; (b) synergizes with other
IFN-y inducers (e.g., IL-2, mitogenic lectins, anti-CD3 anti-
bodies, alloantigenic stimulation, and phorbol diesters) in in-
ducing IFN-y gene expression acting both at the transcrip-
tional and posttranscriptional levels (8, 9) ; (c) enhances the
cytotoxic activity of both resting NK and T cells (1, 10, and
Chehimi et al ., manuscript submitted for publication) ; (d)
directly induces and synergizes with IL-2 in the generation
oflymphokine-activated killer (LAK) cells (2) ; (e) has a comito-
genic effect with mitogenic lectins, anti-CD3, antigenic stim-
ulation, and phorbol diesters on the proliferation of resting
T cells (1, 10a) ; (f) directly induces proliferation of activated
T and NK cells (10a, 11) ; and (g) antagonizes the IL-2-induced
proliferation ofNK cells and both normal and leukemic T
y/8 cells with a mechanism dependent on TNF pro-
duction (10a) .
Although expression of p40 and p35mRNA has been de-
tected in normal murine tissues (5), nothing wasknown about
the ability of normal cells to produce the biologically active
NSKF/IL12 . In this paper, we utilize newly generatedmAbs
against either the p40 or the p35 chains of NKSF/IL12 to
investigate the production ofNKSF/IL12 by normal human
peripheral blood cells. Using these antibodies, RIAs detecting
the NKSF/IL12 free p40 chain, the free p35 chain, or the
p70 heterodimer have been established . Most EBVtransformed
cell lines, constitutively orupon phorbol-diester stimulation,
produce the biologically active p70 and usually a large excess
2Abbreviations used in this paper: NKSF, natural killer cell stimulatory
factor ; PDBu, phorbol dibutyrate; SAC, Staphylococcus aureus Cowan I strain .
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of the free p40 chain, whereas production of the free p35
chain was not demonstrated. PBMC are induced to produce
high levels of both the free p40 chain and the p70 hetero-
dimer by stimulation with fixed Staphylococcus aureus Cowan
I strain (SAC) ; a lower constitutive production was also ob-
served . Both adherent cells and monocyte-depleted nonad-
herent lymphocytes producedNKSF/IL12 in response to SAC
stimulation . The NKSF/IL12 produced by PBMC has bio-
logical activities similar to those of recombinant or EBV
transformed cell line-derived NKSF/IL12, e.g ., IFN-y in-
duction, enhancement ofNK cell cytotoxicity, and mitogenic
effects onT andNK cells . The use of neutralizing antibodies
against NKSF/IL12 allowed us to demonstrate that consti-
tutive or induced NKSF/IL12 production plays a major role
in the IFN-y production by PBMC stimulated by various
IFN-y inducers .
Materials and Methods
NKSFIIL12 Preparations and Assay .
￿
Recombinant NKSF/IL
12 p40 and p35 chains were produced as I1vE fusion proteins and
purified by SDS-PAGE as described (4) . Recombinant NKSF/IL12
free p40 chain was also purified from the supernatant fluid of Cos-1
cells transfected with p40 cDNA, as described (4) . The cDNAs
encoding the p40 and p35 subunits ofNKSF were subdoned into
the mammalian expression vectorpEMC-DHFR (12) to generate
plasmids useful for transfecting monkey Cos-1 cells . Cells were trans-
fected with either cDNA or with a combination of the two ; bio-
logicalNKSFAL12 activity was observed only in the supernatants
of the Cos-1 cells transfected with both cDNA (4) . Pure recom-
binant NKSF, in biologically active heterodimeric p70 form, was
purified from the supernatant of stably transfected CHO cells .
NKSF activity was measured in the IFN-y induction assay (1),
as well as in the blast proliferation assay (11) and the NK cell cyto-
toxicity enhancement assay (1) . 1 U of NKSF/IL12 is defined as
the concentration ofNKSF/IL12 inducing half-maximal induction
ofIFN-y production and was determined to correspond to 3.6pM
ofpurified RPMI 8866-derived NKSF/IL12 (1) . The supernatant
fluids of Cos-1 cells transfected with both cDNAs contained be-
tween 300 and 1,000 U/ml ofNKSF/IL12 . The purified CHO
cell-derived NNKSF/IL12 had a specific activity of 5 x 106 U/mg.
mAb Preparation . 6-wk-old female BALB/c mice were im-
munized subcutaneously in CFA with 5-15 p.g of NNKSF/IL12
or isolated chains, followed by two to three weekly injections of
antigen subcutaneously in IFA . The animals were then injected
intravenously with the same amount ofpurified proteins in saline,
and after 3 d the animals were killed, a spleen cell suspension was
prepared, and then was fused with the BALB/c myeloma cell line
PX63.Ag8.6 .5 .3 . The following antigens were used : purifiedEsch-
erichia coli-derived p40 (fusions C2 and C3) ; purified E. coli-de-
rived p35 (fusion C7) ; purified Cos-1 cell-derived p40 (fusion C8) ;
and purifiedCHO cell-derived NNKSF/IL12 p70 heterodimer (fu-
sion C11) . Supernatant fluids ofgrowing hybrid cells were screened
for production ofanti-NKSF/IL12 antibodies by indirect RIA . An-
tigens (1 Ftg/ml purified recombinant proteins or 3 U/ml semi-
purified RPMI 8866-produced NKSF/IL12) were added to 96-well
vinyl plates (Serocluster; Costar, Cambridge, MA) at 100 P,1/well
in 0 .1 M carbonate buffer, pH 9 .5 . After overnight incubation,
the plates were washed with PBS containing 0.05% Tween 20 (Bio-
Rad Laboratories, Richmond, CA), 100 A1 of supernatant fluid from
hybrid cells were added, and antibody binding was detectedby usingan affinity-purified ...I-labeled goat IgG anti-mouse Ig as second
antibody.
Positive wellswere cloned by limiting dilutions . Isotypes of the
antibodies were determined by immunodiffusion in agar using 20-
fold concentrated supernatant fluids and isotype-specific antisera
(Sigma Chemical Co., St . Louis, MO). All the anti-NKSF/IL12
antibodies described in this paper are of the IgG1 isotype. Anti-
bodies were purified from ascites fluid using a protein G column
(Pharmacia-LKB, Piscataway, NJ) .
Double Determinant RIAs.
￿
Anti-NKSF/IL12 antibodies were
absorbed (5 jig/ml, 100 /Al/well, in 0.1 M carbonate buffer, pH
9.5) for 24 h or longer at 4°C to 96-well vinyl plates. The plates
were washed three timeswith PBS 0.05% Tween-20, dilutions of
standard antigen solutions or supernatant fluids to be tested were
added to the plates (100,ul/well, 18 h, 4°C), the plates were again
washed, and 0.1 wg/ml of a different mAb, labeled with 1261 (chlo-
ramineT method, 1 mCi I'll/20 p,g of protein) was added to the
plates . After an 18-h incubation at 4°C, the plates were washed,
dried, the wells were removed with a hot wire, and radioactivity
was quantitated in a gamma counter (Packard Instruments Co.,
Downers Grove, IL) . In addition to the antibodies described in this
paper, the rat IgGmAb 20C2, reacting with NKSF/IL12 hetero-
dimer but not with isolated p35 or p40 chains (Chizzonite et al .,
manuscript in preparation), was utilized as a 121I-labeled antibody
in an RIA.
Cell LinesandPBMC Preparations.
￿
The humanEBVtransformed
B lymphoblastoid cell lines RPMI 8866, RPMI 7766, RPMI 1788,
NC37, Bristol 8, CESS, andSK-W64 (all obtained from American
Tissue Culture Collection [ATCC], Rockville, MD),RAEB,RW
EB, and SF-EB (established in our laboratory) ; the Burkitt lym-
phoma cell lines Raji and Daudi, the T leukemia cell line Jurkat
J32, andthe myeloid leukemia cell lines HL60 andU937 were grown
in RPMI 1640 supplemented with 10% FCS (Flow Laboratories,
Inc., Rockville, MD). For stimulation ofNKSFAL12 production
by phorbol diester, the cell lines were incubated (24 h, 37°C) at
106 cells/ml in serum-free medium containing or not 10' M
phorbol dibutyrate (PDBu;Chemsy Science Lab, Lexeno, KS) . The
cell-free supernatant fluids used for biochemical or immunological
analyses were in some experiments concentrated 10-fold under pres-
sure using a Diaflo ultrafiltration system with PM10 membranes
(Amicon, Danvers, MA) . Supernatant fluids from PDBu-stimulated
cells, used in IFN-y induction assays, were dialyzed for24 h against
several changes of 0.15 M NaCl followed by 24-h dialysis against
RPMI 1640 . Using [3H]PDBu as a tracer, this treatment was pre-
viously shown to be able to reduce the concentration ofPDBu to
levels without any detectable effects in the various biological
assays (1) .
Peripheral blood obtained from healthy donors was anticoagu-
latedwith heparin . PBMC were separated on Ficoll-Hypaque (F/H)
density gradient (Lymphoprep ; Nyegaard andCo., Oslo, Norway) .
Lymphocytes (PBL) were obtained after adherence of PBMC to
plastic flasks (1 h, 37°C) . Adherent cells were obtained by scraping
the flasks with arubber policeman after carefully rinsing out nonad-
herent cells with three washings with PBS ; these preparations con-
tained >95% CD14' monocytes . In some experiments, monocyte-
freePBLpreparations were obtained after two adherence cycles on
plastics, sensitization with theIgMmAb B52.1 (anti-CD14), elimi-
nation of agglutinated cellsby filtration through nylon wool, and
depletion of the remaining antibody-sensitizedCD14' monocytes
by indirect rosetting with antiglobulin-coated sheep erythrocytes
andF/H gradient separation, as described (13) . These PBL prepa-
rations contained <1% (usually 0.1-0.5%) monocytes, as deter-
mined on each preparation by nonspecific esterase staining.
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PHA blasts were from 6-d PBL cultures (106 cells/ml) con-
taining 1% PHA-M (Wellcome Diagnostics, Dartford, England) .
These preparations were composed of>98% T cells, as determined
by immunofluorescence with antileukocyte subset mAb.
NK cells (blasts) were purified using indirect antiglobulin reset-
ting and negative selection (usingmAbOKT3 [anti-CD3], B36.1
[anti-CD5], andB52.1 [anti-CD14]) from PBMC cultured for 8 d
with 50-Gy irradiated RPMI 8866 cells, as described (14). These
preparations contained >95% CD3 - , CD16', and/or CD56' NK
cells.
Stimulation of NKSF/IL12 production from peripheral blood
cells with fixed SAC was performed by adding 0.0075% (wt/vol)
ofSAC (Pansorbin ; Calbiochem-Behring Co., La Jolla, CA) to the
cells (106/ml), followed by an 18-24-h incubation at 37°C . Cell-
andSAC-free medium was collected by centrifugation and filtering
through0.2-p,m filters . This procedure completely removedSAC,
and in control experiments no residual SAC activity in any of the
biological or immunological assays was determined .
For stimulation of IFN-y, the different inducers were added to
PBL, PHA blasts, or purified NK cells (5 x 106/ml, 200 /Al/well
in 96-well plates) for 18 h, then the supernatant fluids were col-
lected, and IFN-y release was determined in triplicates using an
IFN-y-specific RIA, as described (15) . Thefollowing inducers were
used : various supernatant fluid containing NKSF/IL12; various
preparations of naturalandrecombinant NKSF/IL12, rIL2 (100 U/
MI, 10' U/mg, kindly provided by Dr.J . Taguchi, Osaka Univer-
sity, Osaka, Japan), OKT3 IgG2a anti-CD3 antibody (3 P.g/ml
absorbed to flat-bottomed 96-well plates, Costar) ; SAC (0.0075% ;
wt/vol); and PHA-M (1%) .
The ability of NKSF/IL12 and IL-2 to induce proliferation of
PHA blasts andNK cells was analyzed in a 48-h [3H]thymidine
incorporation assay as described (10a). The NK cell-mediated
rtotoxicity-enhancing activity of NKSF/IL12 was tested by in-
cubating PBL for 18 h with various concentrations ofNKSF/IL
12-containing supernatant fluids ; PBLwere then washed and tested
against "Cr-labeled Daudi target cells, as described (1). In some
experiments sheep anti-IFN-tx serum (Interferon Sciences Inc ., New
Brunswick, NJ), cow anti-IFN-,Q serum (kindly provided by Dr.
Jan VilCek, New York University), or goat anti-IL-2 (produced
in our laboratory) were added to PBL during the 18-h culture be-
fore the NK cell-mediated rytotoxicity assay.
Northern BlotHybridization .
￿
Northern blots were performed as
previously described (16) . TotalRNAwas extracted from induced
and uninduced cell lines and peripheral blood cells by the guani-
dine isothiocyanate method. Equal amounts ofRNA (15 P,g/lane)
were size fractionated in a1% agarose-formaldehyde gel . Ethidium
bromide stained gels were visualized to assess integrity of RNA
and to verify that equal amountsoftotalRNAwere loaded in each
lane. RNA transferred to nitrocellulose paperwas then hybridized
to Sap-cDNA probes for NKSFAL12 p40 and 0-actin . The filters
were autoradiographed and quantitated by densitometry on the ex-
posed film andthe values oftheinduced cells were normalized with
those of theuninduced cells on the basis of hybridization with the
-actin probe.
SDS-PAGE and Western Blotting.
￿
1 ml of 10-fold concentrated
serum-free supernatant fluids from uninduced andinduced RPMI
8866 cells (PDBu stimulation) or PBMC (SAC stimulation) were
immunoprecipitated with mAb C11.79 coupled to Sepharose 4B
(Pharmacia/LKB) . Immunoprecipitated material was loaded onto
5-20% continuous gradient polyacrylamide slab gels and SDS-PAGE
was performed according to the method of Laemmli (17) . After
electrophoresis, resolved proteins were transferred to nitrocellulose
paper using a semi-dry transblotter (Bio-Rad Laboratories) . NKSF/IL12 p70 and NKSF/IL12 p40 were detected by incubation with
1211-labeled anti-NKSF/IL12 rnAb C8.6 followed by autoradio-
graphy.
Results
Production ofmAbs against Human NKSF/IL-12 and Devel-
opment ofSpecfic Quantitative RIAs. After immunization of
BALB/c mice with various preparations ofNKSF/IL12 p35,
p40, and p70, a large panel ofmAbs was obtained . The reac-
tivity of some of these antibodies is illustrated in Fig . 1 . By
indirect RIA, theC2 and C3 series ofmAbs, generated using
Escherichia coli-derived p40 chain as antigen, react with both
E . coli-derived and Cos-derived p40, as well as with CHO-
derived p70 . The C8 series of antibodies, generated using
as antigen Cos-derived p40, have a reactivity similar to that
of theC2 and C3 antibodies, with Cos-derived p40 and CHO-
derived p70, but do not detect E . coli-derived p40 (Fig. 1) .
The C11.5 and C11.79 antibodies, generated against CHO-
derived p70, react with the p40 chain and have a reactivity
similar to that of the C8 series (not shown) . The antibodies
of the C7 series, generated using as antigen E . coli-derived
p35, react withE . coli p35 and with the p70 heterodimer,
but not with either p40 preparation (Fig . 1) . The low or
absent reactivity ofC7 antibodies against semipurifiedRPMI
8866-derived nNKSF/IL12 (Fig. 1 D) is probably due to the
fact that this preparation contains prevalently the free p40
chain and a lower concentration of the p70 heterodimer.
None of the antibodies produced against E. coli-derived
p40 or p35 had a neutralizing activity, whereas a proportion
of the mAbs generated using as antigens Cos-derived p40
or CHO-derived p70 were able to neutralize the biological
activities of NKSF/IL12 . Fig . 2 illustrates the ability of two
of these neutralizing mAbs, C8.1 and C8.6, to inhibit three
different biological activities ofrNKSF/IL12, i .e ., IFN-'Y in-
duction, mitogenic effects onPHA blasts, and enhancement
ofNK cell-mediated cytotoxicity. Both antibodies neutral-
ized all three biological activities, but C8.6 was more efficient
at lower concentrations than C8.1 . By competitive binding,
it was demonstrated that C8.1 and C8.6 bind to two different
determinants on the p40 chain (data not shown) . Similar neu-
tralizing activity was mediated by C8.1 and C8.6 mAbs on
natural and recombinant NKSF/IL12 (data not shown) .
To establish the specificity of the neutralizing effect ofmAb
C8.6, its ability to inhibit proliferation of PHA blasts and
NK cells (blasts) induced by rNKSF/IL12 and rIL2 was as-
sayed (data not shown) . The mitogenic effect ofrNKSF/IL
12 on both T and NK cells was completely abolished by 10
Ag/ml ofC8.6, whereas no effect was observed on IL-2-induced
proliferation .
All possible combinations of >30 mAbs were tested in
double-determinant RIA for detection ofNKSF/IL12 or its
chains . Several combinations were effective, and the most sen-
sitive and useful combinations are illustrated in Fig. 3 . The
combination of the two anti-NKSF/IL12 p40 antibodies,
C11.79 and 1251-labeled C8.6, detects both the free p40 chain
and the p70 heterodimer with approximately equal efficiency.
The combination of the anti-p40 mAb C8.3 and 1251-C8.6
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￿
Indirect RIA ofrepresentative anti-NKSF/IL12 rnAb tested
against various preparations of NKSF/IL12 or its free chains. PurifiedE .
coli-derived p35 chain (A), E . coli-derived p40 chain (B), Cos-derived p40
chain (C), semipurified RPMI 8866-derived NNKSF/IL12 (both p40 and
p70) (D), and pure CHO-derived NNKSF p70 heterodimer (E) were ad-
sorbed to 96-well vinyl plates, and binding of the indicated mAb was de-
tected with a second 1211-labeled affinity-purified goat antibody anti-mu-
rine Ig.
detects only the free p40 chain and not the p70 heterodimer,
probably due to the inability of C8.3 to efficiently bind to
the p40 chain when complexed with the p35 chain, as indi-
cated by the results of indirect RIA in Fig . 1 . A combination
oftwo anti-p35 mAbs, C7.4 and 1251-C7.8, was very sensi-
tive in detecting the free p35 chain, but not the p70 hetero-
dimer. All of the combinations of anti-p35 mAb with anti-
p40 mAb were tested in an attempt to obtain a RIA specificE
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Figure 2 .
￿
Ability of anti-NKSF/IL12 mAb to neutralize NNKSF/IL12
biological activities. The indicated concentrations of purified IgG1 mAbs
C8 .1 (A) and C8 .6 (A) were added to NNKSF/IL12 (0 .2 ng/ml, A, C,
and E ; 1 ng/ml, B, D, and F), and the ability of NNKSF/IL12 to induce
IFN--y production from PBL (A and B), induce proliferation ofPHA blasts
(CandD), and enhance PBLmediated spontaneous cytotoxicity ofDaudi-
target cells (E/T cell ratio of 50 :1, E and F) was tested as described . In
each panel the dashed line indicates the activity of cells not treated with
NNKSF/IL12, and the dash-dot-dash line indicates the activity of cells treated
with NNKSF/IL12 in the absence of mAb .
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r
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for the p70 heterodimer, but unexpectedly, none of these com-
binations were effective . This was surprising because in in-
direct RIA (Fig . 1) or by Western blotting (not shown) most
of these antibodies were able to react with the p70 hetero-
dimer. However, the combination of the anti-p40mAb C11.5
with the 1251-labeled mAb 20C2 (reacting with the p70 het-
erodimer but not with either free chain ; Chizzonite et al .,
manuscript in preparation), was relatively specific for the p70
heterodimer. A limited crossreactivity with free p40 chains
was observed, however, with a plateau at 1,000-4,000 cpm
reached at concentrations of p40 >1 ng/ml . To quantitate
p70 in the presence of free p40, this RIA was performed in
parallel with the C8 .3/125I-C8.6 RIA to measure free p40 .
The counts per minute obtained in the C11.5/ 1251-20C2
assay were corrected by subtracting the crossreactive amount
expected on the basis of the determined free p40 chain con-
centration and used to determine p70 concentration . Because
of this necessary correction, the assay was only able to ac-
curately quantitate p70 in the presence offree p40 when the
concentration of p70 was higher than at least 100 pg/ml .
A 10-fold concentration of the supernatant fluid from cell
lines or peripheral blood cells was usually required in order
to quantitate p70 .
Production ofNKSF/IL-12 by Human Cell Lines .
￿
The su-
pernatant fluids of a large number of cell lines were analyzed
for production ofthe free p40 chain and the p70 heterodimer.
Results with representative cell lines are illustrated in Fig.
4 . Most EBVtransformed human B cell lines produced the
free p40 chain and this production was significantly enhanced
by stimulation with phorbol diesters. Only a low level of
p70 was constitutively produced by RPMI 8866 and NC37
cell lines, but a larger group of EBVtransformed B cell lines
produced p70 upon phorbol diester stimulation . Although
Figure 3 .
￿
Double determinant RIAs with anti-NKSF/
IL-12 antibodies . The indicated different pairs of mAbs
were used in RIA as described using as standards purified
CHO-derived p70 NKSF/IL12 heterodimer (/), Cos-
derived p40 (A), and E. coli-derived p35 (" ) .3
2
A
300
200-
100
C
most in vitro EBVtransformed cell lines produce at least the
free p40 chain, almost no production ofNKSF/IL12 was ob-
served from the two Burkitt lymphoma-derived cell lines,
Daudi and Raji . Several T cell lines (Jurkat J32, Fig . 4; and
others, not shown), myeloid leukemic cell lines (HL-60 and
U937, Fig . 4; and ML-3 and THP-1, not shown) and many
solid tumor-derived cell lines (melanoma, coloncarcinoma,
and others, not shown) did not produce NKSF/IL12 con-
stitutively or upon stimulation with phorbol diesters. The
relative production of p40 and p70 by the stimulated and un-
stimulated RPMI 8866, CESS, Raji, and Daudi cell lines was
confirmed by Western blotting (data not shown) . Significant
production of the free p35 chain was never observed with
any cell line (not shown) . The presence of transcripts for the
p40 and p35 genes was analyzed by reverse transcriptase (RT)
PCR ; whereas the accumulation of the p40 transcript was
restricted to the cell lines producing p40 and p70, the tran-
scripts ofthe p35 gene weremuch more ubiquitous and present
in many cell lines, including most T, myeloid, and solid tumor
cell lines (data not shown, and 18) .
The presence of the p70 heterodimer in the supernatant
fluids from either PDBu-stimulated or unstimulated cells par-
alleled the presence of IFN-y-inducing activity (Fig. 4, C
and D) . The ability of C8.6 mAb anti-NKSF/IL12 to al-
most completely abolish the IFN-y-inducing ability of the
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Figure 4 .
￿
Constitutive and phor-
bol diester-induced production of
free p40 chains and biologically ac-
tive p70 heterodimersby human cell
lines. Cell-free supernatant fluids
from the indicated cell lines were ob-
tained after an 18-h incubation in
the absence (A and C) or presence
(B and D) of 10-7 M PDBu . The
concentration of the p70 hetero-
dimer (C11.5/ 125I_20C2 RIA, filled
portion ofthe bars, A and B) and of
the free p40 chain (C8.3/125I-C8 .6
RIA, openportion ofthe bars) was de-
termined . For determination of
IFN-y-inducing activity (C andD),
the supernatant fluids (after exten-
sive dialysis of those containing
PDBu) were added at dilutions of
1 :2 to purifiedNK cells (blasts) in
the presence of100 U/ml rIL2 . The
values reported arethe difference be-
tween IFN-y production in the pre-
sence and in the absence of 10 Rg/
ml C8.6 neutralizing anti-NKSF/
IL-12 n Ab.
supernatant fluids of the cell lines confirms that this activity
was due to NKSF/IL12 .
Production of NKSFIII-12 by Normal Peripheral Blood
Cells. As shown in Table 1, PBMC constitutively produced
in culture low but detectable levels of the free p40 chain and
the p70 heterodimer. Monocyte-free PBL and adherent cells
(>95% monocytes) produced equivalent amounts ofNKSF/
IL-12 . Unlike B cell lines, stimulation with phorbol diester
did not significantly increase NKSF/IL12 production by pe-
ripheral blood cells . Among many different possible inducers
tested, SAC presently appears to be the most powerful, in-
creasing production of both the free p40 chain and the p70
heterodimer. No production of the free p35 chain was de-
tected by RIA (data not shown) . After SAC stimulation, ad-
herent cells were more efficient than PBL in producing
NKSF/IL12 p40, but less efficient in producing the p70 het-
erodimer. Monocyte contamination (<1% as determined by
nonspecific esterase staining) could not account for the level
ofNKSF/IL12 production by the PBL preparations. Other
inducers ofNKSF/IL12 from PBMC were LPS (E. coli, sero-
type 0127:B8 ; 1 NAg/ml) and Mycobacterium tuberculosis (H37
RA nonviable desiccated; 1 Fkg/ml) . On average, LPS and
M. tuberculosis induced 6% and 8%, respectively, of theSAC-
induced NKSF/IL12 p40 production in the same PBMC
preparations . Various recombinant cytokines tested (IL-1(x andTable 1 .
￿
Production of the Free NKSF/IL-12 p40 Chain and the p70 Heterodimer by PBMC in Response to SAC Stimulation
0, 1 lt,g/ml; IL2, 1,000 U/ml ; IL4, 100U/ml ; IL6, 200 U/
ml ; IFN-1' and -,(3, 1,000 U/ml ; TNF a and ,(3, 100 ng/ml ;
GM-CSF, 100 ng/ml) were unable to enhance NKSF/IL12
p40 production from PBMC .
The ability ofSAC to induce NKSF/IL12production was
confirmed at themRNA levelby Northern blot analysis (Fig.
5) . SAC increased the accumulation of p40 mRNA two- to
three-fold in monocytes and induced it from undetectable levels
in monocyte-free PBL . Production in response to SAC of the
Figure 5 .
￿
The accumulation of NKSF/IL12 p40 mRNA is enhanced by
phorbol diester stimulation of the RPMI 8866 cell line and by SAC stimula-
tion of adherent PBMC and PBL. Total RNA was extracted from RPMI
8866 unstimulated (-) or stimulated with 10-7MPDBu (+) and from two
preparations of plastic-adherent PBMC (indicated as Monocytes in the figure
and containing >95% CD14' cells) and one preparation of monocyte-
depleted PBL, PHA blasts, andNKcells unstimulated (-) or stimulated with
0.0075% (wt/vol) SAC(+) . The Northern blot was hybridized with 32p-
cDNA for p40 NKSF/IL12 and for /3-actin. For densitometric analysis of
the hybridization with p40cDNA (top), the values ofthe induced and unin-
duced cells are corrected according to the relative intensity of/3-actin hybrid-
ization .
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PBMC, monocyte-free PBL, and plastic-adherent cells (>95% monocytes) from eight donors were cultured (106 cells/ml, 18 h, 37 °C) in the presence
or absence of SAC . Supernatant fluids were collected, and the p40 chain and the p70 heterodimer concentrations were determined by RIA .
p40 chain was also observed by RIA andby Northern blot-
ting in 7-d cultures of monocyte-derived macrophages (not
shown) . PHA blasts (mostly activated T cells) and purified
cultured NK cells showed neither significant accumulation
of p40 mRNA (Fig . 5) nor secretion of p40 or p70 (not
shown) .
The ability ofSAC to induce both p40 and p70 produc-
tion was confirmed by Western blotting using immunopre-
cipitated supernatant fluids from both unstimulated and SAC-
stimulated PBMC (Fig. 6) . Western blotting analysis with
anti-p40 antibody C8.6 did not detect constitutive produc-
tion ofp40 or p70by PBMC from two donors, whereas these
proteins were observed in the supernatant fluids of the same
Figure 6.
￿
Western blotting analysis ofrecombinant and natural NKSF/IL
12. Western blotting was performed as described using 1 ng CHO cell-de-
rived NNKSF/IL12 and immunoprecipitates with antibody C11.79 (anti-p40)
from the supernatant fluid (1 ml, 10-fold concentrated) of RPMI 8866 cells,
stimulated or not with 10 -7M PDBu, or ofPBMC from two donors (A
and B), stimulated or not with 0.0075% SAC. 12s1-labeled antibody C8 .6
was used for detection of the blotted NKSF/IL12 . The supernatant fluids
from SAC-stimulated PBMC from donors A and B were the same as those
used for the experiments in Fig. 7 .
Responder cells"'
None
p40 p70
Stimulation
SAC 0.0075%
p40
(wt/vol)
p70
pg/ml (mean ± SE)
PBMC 774 ± 297 31 ± 19 4,953 ± 1,844 623 ± 252
PBL 221 ± 109 25±7 3,557 ± 1,556 557 ± 209
Adherent cells 288 ± 88 10±2 7,109 ± 1,995 304 ± 139PBMC preparations stimulated with SAC for 18 h . In the
40-kD region, two bands were observed in supernatants from
bothPBMC andRPMI 8866 . These multiple bands are prob-
ably explained by differential glycosylation of the p40 chain .
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￿
Biological activity of SAC-induced NKSF/IL12 produced by
PBMC. PBMC from healthy donors A and B were cultured (106 cells/ml,
1% FCS, 18 h at 37°C) in the presence of 0.0075% SAC, supernatant
fluids were collected, and concentrated 10-fold. The concentration of the
p70 heterodimer, as determined by RIA, in 10-fold concentrated superna-
tant fluids from donors A and B, were 1 .8 and 1.2 ng/ml, respectively.
Twofold dilutions of the concentrated fluids were thentested for their ability
to induce proliferation of PHA blasts ([H]TdR incorporation, 48-h cul-
tures), induction of IFN- -y production by purified NK cells (5 x 106
cells/ml, 18-h cultures, in the presence of 100 U/ml rIL2), and enhance-
ment ofNK cell-mediated cytotoxicity. 2 x 105 PBL were incubated for
18 h in round-bottomed 96-well plates in the presence of dilutions of su-
pernatant fluid or NNKSF/IL12 and in the presence of anti-IFN-a, anti-
IFN-/3, and anti-IL2 antibodies; S'Cr-labeled Daudi cells were then added
(104/well) and supernatant fluid for determination of S'Cr-release were col-
lected after 3 h . All experiments were performed in the presence (dashed
lines and open symbols) or absence (solid lines and filled symbols) of anti-
NKSF/IL12 antibodies C8 .6 and C8 .1 (10 Ag/ml each) . The continuous
horizontal dashed line indicates the control values in the absence of super-
natant fluids or NNKSF/IL12. (" and O) NNKSF/IL12 ; (" and q) Su-
pernatant fluid of donor A ; (A and 0) supernatant fluid of donor B.
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In the 70-kD region, presumably corresponding to the het-
erodimer, two bands with slightly faster and slower migra-
tions, respectively, than the main band observed with CHO
cell-derived p70 heterodimer were observed in the superna-
tant fluid of PDBu-stimulated RPMI 8866 cells and SAC-
stimulated PBMC . The larger band was predominant in the
supernatant fluid from RPMI 8866 cells, whereas the smaller
band was predominant in the supernatant fluid fromPBMC .
The exact chemical basis of this microheterogeneity and its
possible functional relevance remain to be investigated .
As shown in Fig. 7, the SAC-stimulated supernatant fluids
from SAC-stimulated PBMC were able to mediate enhance-
ment ofNK cell cytotoxicity, production of IFN-y, and mito-
genic effects on NK cells (blasts) at concentrations of p70
roughly equivalent to the concentrations ofNNKSF/IL12 with
similar activity. The activities mediated by the supernatant
fluids were partially abolished by neutralizing anti-NKSF/IL12
antibodies, suggesting that, in addition toNKSF/IL12, other
factors produced by PBMC might be effective in these assays .
However, the inability of the mAbs to inhibit completely
the three biological functions could also be due in part to
the presence in the supernatant fluid not only of the p70 chain,
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Figure 8 . . NK cell-mediated cytotoxicity-enhancing activity of SAC-
induced supernatant fluid from PBMC. PBL from a normal donor were
cultured (5 x 106 cells/ml, 18 h, 37°C) in medium (dashed lines) or in
the presence (solid lines) of supernatant fluids from SAC-stimulatedPBMC
(same donor A as in Figs. 6 and 7) at a dilution corresponding to a concen-
tration of0 .3 ng/mlNKSFAL12 p70 . The following antibodies werepresent
during the culture: (O and" ) no antibody ; (,L and A) sheep anti-IFN-a
(1:200) and cow anti-IFN-/3 (1:200) ; (q and" ) goat anti-IL-2 (1:200) ; (E]
and /) anti-IFN and anti-IL-2 . Open symbols refer to cultures in the ab-
sence, and filled symbols to cultures in the presence, of anti-NKSF/IL12
C8 .6 and C8 .1 antibodies (10 jig/ml each) . PBL were then washed and
tested at the indicated E/T cell ratio against S'Cr-labeled Daudi target
cells in a 3-h cytotoxic assay.but also of an excess of the free p40 chain, competing with
the biologically active heterodimer for binding to the anti-
p40 antibodies. The presence of other factors in the superna-
tant fluid able to mimic NKSF/IL12 function was directly
evaluated for NK cell-mediated cytotoxicity enhancement .
As shown in Fig. 8, anti-IFN a//3, anti-NKSF/IL12, and,
to a lesser extent, anti-IL-2 antibodies partially blocked the
enhancing ability of the supernatant fluid ofSAC-stimulated
PBMC to enhance NK cell-mediated cytotoxicity . An almost
complete inhibition was observed using a combination ofanti-
IFN a/(3 and anti-NKSF/IL12 antibodies. These results in-
dicate that NKSFAL12 and IFN a/o represent the two pre-
dominant factors contained in the supernatant fluid with the
ability to enhance NK cell-mediated cytotoxicity, with a pos-
sible minor role for IL-2 and other nonidentified factors.
Role ofEndogenous NKSF/IL12 in theIFN-y Production by
PeripheralBlood Cells in Response to Various Inducers. As shown
in Table 2, the mAb C8.6 at a concentration of 10/, .g/ml
inhibits >95% of the IFN-y production induced by 1 ng/ml
ofrNKSF/IL12 . The NKSF/IL12 inducer SAC was also a
powerful stimulator of IFN-y production by PBL . SAC-
induced IFN-y production was inhibited >80% by the mAb
C8.6, suggesting that it was mostly dependent on SAC-
induced NKSF/IL12 . However, the IFN-y-inducing ability
of stimuli such as rIL2, PHA, and anti-CD3 antibodies that
do not induce NKSFAL12 was also inhibited -50% by the
mAb C8.6 . Similar results were obtained with other neu-
tralizing anti-NKSF/IL12 p40 antibodies, whereas in several
experiments nonneutralizing anti-p40 and anti-p35 antibodies
as well as irrelevant isotype-matched antibodies did not in-
hibit IFN-'y production . It is likely that the inhibition reflects
a role for low levels of constitutively expressed NKSF/IL12
acting synergistically with the three stimuli to induce IFN-y
production . It is ofinterest that whenIFN-y production was
analyzed using purified NK cells (Table 2) or PHA blasts (not
shown), which are unable to produce NKSF/IL12, SAC did
Table 2 .
￿
Ability ofAnti-NKSF/IL-12 Antibodies to inhibit
IFN-y Production by Human PBL and Purified Cultured NK Cells
Fresh PBL or purified cultured NK cells were cultured for 18 h with
the various inducers at the indicated concentration in the presence or ab-
sence of 10 wg/ml C8 .6 antibody, and percent inhibition of IFN-.y produc-
tion was evaluated .
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not induce IFN-y production, whereas the IFN-y-inducing
activity of rIL2, unlike that observed with PBMC, was not
inhibited by C8.6 mAb. As expected, however, C8.6 mAb
almost completely inhibited the NNKSF/IL12-mediated IFN-y
induction in both NK cells and PHA blasts.
Discussion
In the last two years, we and other laboratories have charac-
terized many of the biological functions of NKSF/IL12 on
T and NK cells. These studies have shown that NKSF/IL12
has important regulatory effects on the proliferation, cyto-
toxic ability, and lymphokine production from these two cell
types. However, the lack ofinformation on whether NKSF/IL
12 was produced by normal cells and by which cell types
precluded the determination of a possible physiological in vivo
role of NKSF/IL12 .
In this paper, we have addressed the question ofthe produc-
tion ofNKSF/IL12 by cell lines and normal peripheral blood
cells utilizing newly generatedmAbs as well ascDNA probes .
mAbs toNKSF/IL12 have been previously described (19) and
two anti-p40 antibodies were used for the establishment of
anELISA (19) . However, the sensitivity of theimmune assay
was low and the interpretation of the results was compli-
cated by the fact that it was not clear whether the assay mea-
sured the biologically active p70 heterodimer, the free p40
chain, or both . Because cell lines (1, 3) and, as shown in this
paper, PBMC consistently produce an excess of the free p40
chain over the p70 heterodimer, assays able to separately quan-
titate the p40 and p35 free chains and the p70 heterodimer
were necessary. Testing various combinations of mAbs, we
were able to establish four sensitive RIAs that specifically
quantitated : (a) the free p40 chain, (b) the free p35 chain,
(c) both the free p40 chain and the p70 heterodimer, and (d)
the p70 heterodimer only. The specificity and the ability of
different antibodies to be effective in these RIAs could not
be determined on the basis of their known reactivity in other
assays (e.g., indirect RIAs with plastic-bound antigens, im-
munoprecipitation, or Western blotting), indicating that the
different conditions ofthe assay (e.g., the use ofplastic-bound
or soluble, unlabeled or 'III-labeled antibodies, soluble or
plastic-bound antigens) might affect the specificity and affinity
of the antibodies . In particular, it was surprising that pairs
ofanti-p40 and anti-p35 antibodies were unable to detect the
p70 heterodimer. To establish a RIA selectively detecting the
p70 heterodimer, we used the anti-p40 mAb C11.5 bound
on plastic and soluble I'll-labeled 20C2 mAb for detection .
This latter antibody detects only the p70 heterodimer and
not the free p35 or p40 chains. Its reactivity with human/
mouse chimeric rNKSF/IL12, in which the p35 chain was
of human origin but not with those with the p40 chain of
human origin, suggests that 20C2 mAb reacts with human
p35 onlywhen complexed with eitherhuman or murine p40
in the heterodimer (Chizzonite et al ., manuscript in prepara-
tion) . However, our results, showing a low but definite cross-
reactivity with purified Cos-derived p40, support the alter-
native possibility that 20C2mAb reacts with a conformational
Producer
cells Stimulus Concentration
Percent
inhibition (n)
mean ± SE
PBL" rNKSFAL-12 1 ng/ml 95.2 ± 0.8 (16)
PBL rIL-2 100 U/ml 64.9 ± 4.0 (16)
PBL PHA 1% 42.5 ± 4.1 (6)
PBL OKT3 3 hg/ml 42.7 ± 11 .8 (9)
PBL SAC 0.0075% (wt/vol) 83.1 ± 3.0 (14)
NK rNKSFAL-12 1 ng/ml 90.0 ± 2 .2 (4)
NK rIL-2 100 U/ml 5 .8 ± 3 .9 (4)determinant on bothhuman and murine p40, expressed only
when they are in association with human, but not murine, p35 .
All the neutralizing antibodies against NKSF/IL12 de-
scribed by us (4, and this paper) or by others (19), with the
possible exception of the 20C2 antibody described above, are
specific for the p40 chain . Although thismay be due to trivial
reasons (such as the higher antigenicity of p40 or the use
of conformationally altered bacteria-derived proteins for
production of the anti-p35 antibodies), it is possible that ei-
ther p40 or both p40 and p35 are involved in receptor binding .
The latter possibility is supported by the data indicating that
p35 determines the specificity of the p70 heterodimer for
binding to the human or murine receptor (5) . However, it
is possible that the p35 chain does not directly participate
in the binding but is responsible for determining in p40 con-
formational modifications, possibly recognized by 20C2 mAb,
responsible for binding to either the human or the murine
receptor .
We used the RIA to analyze the ability of different human
cell lines to produce NKSF/11,12 . As expected from the pre-
viously published results, showing that threeEBVtransformed
(20) cell lines (RPMI 8866, ADP, and NC37) produced
NKSF/IL12 (1, 2), we observed that most EBVtransformed
cell lines produce NKSF/IL12, constitutively, and that this
production is increased several-fold by stimulation with
phorbol diesters. Within the sensitivity of our RIA, only
two cell lines (RPMI 8866 and NC37) were found to pro-
duce p70 constitutively, but a large number of the cell lines
were induced to produce it upon stimulation with phorbol
diester. All these cell lines also produced an excess of the free
p40 chain over the p70 heterodimer. As expected, on the basis
of the knowledge that only the p70 heterodimer has biolog-
ical activity (1, 4), the ability of the supernatant fluids of
the cell lines to induce IFN-y production paralleled the level
of production of the p70 heterodimer .
The significance of the production of the free p40 chain
by cell lines, and, as discussed below, by normal cells, is un-
clear. It is possible that the p40 chain serves as a carrier for
proteins other than p35, to which it might associate in a non-
covalent way and from which it dissociates in SDS. Alterna-
tively, the free p40 chain might have biological functions
different from those mediated by the p70 heterodimer and
not yet determined. Unlike p40, we have been unable to dem-
onstrate secretion of free p35 from cell lines or normal cells,
although the p35 mRNA was found to be expressed in a
much more ubiquitousway than p40 and it accumulates, for
example, not only in B cell lines, but also in T and myeloid
cell lines as well as in normal T and NK cells, all cell types
not expressing p40mRNA and not producing NKSF/IL12
(18) .
When PBMC were analyzed for production ofNKSF/IL
12, it was found that these cells constitutively produced the
p70 heterodimer and the free p40 chain . Unlike B cell lines,
phorbol diester was not an inducer ofNKSF/IL12 produc-
tion in PBMC. A preliminary search ofmany different com-
pounds able to induce cytokine production in B and other
cell types identified SAC as the most powerful inducer of
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NKSF/IL12 production by PBMC . Constitutive and SAC-
induced production of p40 and p70 was observed both in
adherent cell preparations, composed mostly of monocytes,
and in monocyte-depleted PBL preparations. The inability
of purified activated T andNK cell preparations to accumu-
late p40mRNA and to produce NKSF/IL12 proteins, even
when stimulated by phorbol diesters, IL-2 and/or anti-CD3
or anti-CD16 antibodies, suggests that normalB cells, present
in the PBL preparation, similarly to the transformed B cell
lines, might be, together with adherent PBMC, one of the
NKSF/IL12 producer cell types . Preliminary experiments of
cell depletion showed that removal from PBL of CD19+,
CD20+ B cells significantly reduced, and removal of HLA
class II+ cells almost completely suppressed, NKSF/IL12
p40 production in response to SAC stimulation . The ability
ofSAC to stimulate both B cells (possibly because of binding
ofprotein A to VHIII-associated crossreactive idiotypes) and
monocytes is consistent with previously reported observations
(20, 21) . It is, however, of interest that protein A or Staphy-
lococcus enteroxin A or B did not substitute for the intact
SAC in stimulating NKSF/IL12 production . In addition to
SAC, various other stimuli were shown to induce NKSF/
IL-12 production, although less efficiently . These inducers,
which are presently being investigated in detail, include LPS
andM . tuberculosis . The ability ofSAC to stimulate NKSF/IL12
was paralleled by induction of p40 mRNA in PBL and an
enhancement ofthe constitutive expression of the p40 mRNA
in adherent PBMC . It should be pointed out, however, that
the experiments presented in this paper have not been per-
formed in strictly endotoxin-free medium, and it is possible
that the accumulation ofp40mRNA and production ofp40
and p70 by uninduced adherent PBMC might be dependent
on the stimulation by endotoxin present in the culture
medium .
The p70 heterodimer produced by SAC-stimulated PBMC
has the same biological activities and it is active at similar
concentrations as either rNKSF/IL12 or B cell line-derived
NKSF/IL12 . When stimulatedby SAC, PBMC, at a cellular
concentration of 106/ml, below that present in vivo in pe-
ripheral blood or in other lymphoid organs, produced bio-
logically active NKSF/IL12 at concentrations several-fold above
those required for biological functions, suggesting that
NKSF/IL12 has important physiological roles in vivo. It is
of interest that, similarly to B cell lines, PBMC also produce
an excess of the free p40 chain, indicating that production
of the isolated chain is not due to a dysregulation in trans-
formed cells and renewing the question about the significance
of this finding.
The use of neutralizing antibodies against NKSF/IL12 has
clearly shown that NKSF/IL12 is required for optimal IFN-y
production by PBL, not only in response to NKSF/IL12-
inducing stimuli such as SAC, but also to noninducing stimuli
such as IL2, anti-CD3 antibodies, or PHA . In the case of
these three inducers, the ability ofthe constitutively produced
NKSF/IL12 to participate in the induction of IFN-'y is prob-
ably due to the ability ofNKSF/IL12 to synergize with those
stimuli in inducing IFN-y production (1, 8) .Theability ofmonocytes/macrophage and possiblyBcells
to secrete NKSF/IL12 at biologically active concentrations
strongly suggests that this rytokine may play an important
role in the regulation ofT and NK cells during a localized
immune response and during inflammation . It is important
to point out that although monocytes and B cells produce
several cytokines (e.g ., IL 1, IL-6, TNF, TGF-,l3) with modu-
lating effects on T andNK cell functions, NKSF/IL12 is the
only rytokine known to be produced by these cells that has
a direct effect on proliferation, cytotoxicity, and rytokine
production, acting at much lower molar concentrations than
other cytokines (1). The abilityofbacteria to induce NKSF/IL
12 production suggests that this molecule could play a role
in determining the immune response to bacterial infection .
It has been shown that in SCID mice, IFN-y production
by NK cells in response to Listeria (22, 23) or Toxoplasma
(A . Sher, personal communication) requires the interaction
of both NK cells andmacrophages with themicroorganisms .
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